Literature DB >> 11411868

Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.

K Horita1, A Yamaguchi, K Hirose, M Ishida, S Noriki, Y Imamura, M Fukuda.   

Abstract

In order to identify the prognostic factors that significantly influence the disease-free survival rate after surgical resection of primary breast cancers, we determined tumour and lymph node grades, and immunohistochemical staining for estrogen and progesterone receptors (ER and PR), c-erbB-2, p53, bcl-2, bax and PCNA in 76 patients. Univariate analysis showed that increased grade of tumour and lymph nodes, negative immunostaining for ER, positive immunostaining for c-erbB-2, and a high PCNA index (> or = 30%) negatively influenced the disease-free survival rate, but PR, p53, bcl-2 and bax had no predictive value. Although p53 was not an independent prognostic factor by itself, the combination of p53, bcl-2, and bax proved to correlate with the disease-free survival, with the best prognosis noted in tumours negative for p53 and positive for both bcl-2 and bax, intermediate prognosis in tumours negative for p53 and positive for either bcl-2 or bax and worst prognosis in tumors negative for p53 as well as bcl-2 and bax. Tumour grade correlated positively with PCNA index, while positive staining for ER correlated negatively with tumour grade as well as with PCNA index, although this was statistically insignificant. Immunostaining of breast cancers for bcl-2 correlated negatively with tumour grade and PCNA index. Immunostaining for c-erbB-2 correlated positively with PCNA but not with tumour grade. Immunostaining for p53 tended to correlate positively with PCNA, but not with tumour grade. Immunostaining for PR and bax did not correlate with tumour grade and PCNA index. These results suggest that in addition to tumour size and lymph node involvement, immunostaining for ER, c-erbB-2, and a high PCNA index are important prognostic factors in human breast cancer. Wild-type p53 with preserved bcl-2 and bax gene products is also a favorable prognostic factor indicating breast cancer at an early stage of cancer progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411868     DOI: 10.4081/1616

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


  9 in total

1.  A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Authors:  Natalya Frolova; Mick D Edmonds; Thomas M Bodenstine; Robert Seitz; Martin R Johnson; Rui Feng; Danny R Welch; Andra R Frost
Journal:  Tumour Biol       Date:  2009-07-16

2.  Relationship between CYP3A activity and breast cancer susceptibility in Chinese Han women.

Authors:  Ping Huang; Bing Zhu; Lian-Sheng Wang; Dong-Sheng Ouyang; Song-Lin Huang; Xiao-Ping Chen; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2003-08-22       Impact factor: 2.953

3.  Study of hormone receptors and epidermal growth factor expression in invasive breast cancers in a cohort of Western India.

Authors:  Hardik Dodiya; Amit Patel; Dipal Patel; Ashish Kaushal; D G Vijay
Journal:  Indian J Clin Biochem       Date:  2013-01-03

4.  Characterisation of the progression of azaserine-induced rat pancreatic adenocarcinoma by proliferative cell nuclear antigen, basement membrane laminin and trypsinogen immunohistochemistry.

Authors:  Krisztina Nagy; Zsolt Pálfia; Gábor Réz
Journal:  Histochem Cell Biol       Date:  2003-05-13       Impact factor: 4.304

5.  Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors.

Authors:  Matthew E Hardee; Rose J Eapen; Zahid N Rabbani; Matthew R Dreher; Jeffrey Marks; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-26       Impact factor: 3.333

6.  Landmark Prediction of Survival for Breast Cancer Patients: A Case Study in Tehran, Iran.

Authors:  Behnaz Alafchi; Leili Tapak; Omid Hamidi; Jalal Poorolajal; Hossein Mahjub
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

7.  Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells.

Authors:  Cheng Wang; Jie Yu; Caleb B Kallen
Journal:  PLoS One       Date:  2008-10-24       Impact factor: 3.240

Review 8.  Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes.

Authors:  Yun Lu; Chang-Sheng Li; Qian Dong
Journal:  J Exp Clin Cancer Res       Date:  2008-08-21

9.  Down-regulation of hK7 in the sera of breast cancer and benign breast disease patients.

Authors:  Samina Ejaz; Faiz-Ul-Hassan Nasim; Muhammad Ashraf; Gulzar Ahmad
Journal:  Heliyon       Date:  2017-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.